SBRI Healthcare ProgrammeAn NHS England funded initiative delivered by the Eastern Academic Health Science Network
www.sbrihealthcare.co.uk@sbrihealthcare
Agenda18th June, Birmingham
13.45 Welcome from Chair Dr Christopher Parker, Managing Director, West Midlands Academic Health Science Network (WMAHSN)
13.55 Overview of the SBRI Healthcare Programme – Karen Livingstone, National Director, SBRI Healthcare
14.15 The application & assessment process – Nick Offer, SBRI Healthcare Project Manager, Health Enterprise East
14.35 Theme Presentations - focusing on:• Faecal and Urinary Incontinence• Functional Difficulties• Falls
15.35 Q&A session (All speakers)
16.00 Event close
Helping the Public Sector address challenges• Using innovation to achieve a step change
Accelerating technology commercialisation • Providing a route to market
Support and the development of Innovative companies • Providing a lead customer/R&D partner • Providing funding and credibility for fund raising
SBRI is a pan-government, structured process enabling the Public Sector to engage with innovative suppliers:
SBRI Key features 100% funded R&D Operate under procurement rules rather than state aid
rules UK implementation of EU Pre-Commercial Procurement Deliverable based rather than hours worked or costs
incurred• Contract with Prime Supplier
Who may choose to sub contract but remains accountable• IP rests with Supplier
Certain usage rights with Public Sector – Companies encouraged to exploit IP
• Light touch Reporting & payments quarterly & up front
Things to Note• Any size of business is eligible• Other organisations are eligible as long as the route to market is
demonstrated• All contract values quoted INCLUDE VAT• Applications assessed on Fair Market Value• Contract terms are non-negotiable• Single applicant (partners shown as sub contractors)• Applicants must fully complete the application form
• Labour costs broken down by individual• Material Costs (inc consumables specific to the project)• Capital Equipment Costs• Sub-contract costs• Travel and subsistence• Other costs specifically attributed to the project• Indirect Costs:
o General office and basic laboratory consumableso Library services/learning resourceso Typing/secretarialo Finance, personnel, public relations and departmental serviceso Central and distributed computingo Cost of capital employedo Overheads
Eligible costs (all to include VAT)
www.innovateuk.org/sbri
website contains details of all SBRI competitions
The NHS Innovation Agenda
We will double our investment in the Small Business Research
Initiative to develop innovative solutions to healthcare challenges, encourage greater competition in
procurement of services, and drive growth in the UK SME sector
15 Academic Health Science Networks
Created AHSNs
Lead SBRI
SBRI Process
Problem Identification Open call to Industry
Feasibility Testing
Prototype development
Pathway testing & Proof of Value
AHSN led - typically undertaken by
clinicians – service driven
AHSN led - Workshops
with industry to support
understanding
Assessm
ent
PHASE 1: Typically 6 months – max of
£100k
PHASE 2: Typically 12 months – milestones agreed & monitored
Op
en P
rocu
remen
tDue diligence & contracts
PHASE 3: Typically 12 months –
milestones agreed & monitored
Assessm
ent
New Competition Spring 2015
Competition launch: 15 June 2015Closing Date: Noon 11th August 2015Industry workshops: 18th June, Birmingham; 25th June, LondonContracts awarded: November 2015
Urinary & faecal ContinenceMinimising impact of falls Functional needs
Case study:
£1,458,158 awardedEstimated savings at £1 billion per annum
Product available now60 employees directly created as a result of SBRI
funding. Approximately £2 million of additional investment has
also been secured by the company.
“There is no contest that I would choose the mask over the laser treatment. It is easy to use and
removes any traumatic experience that occurred when
having my eyes lasered.”
POLYPHOTONIX
The PolyPhotonix bio-photonic research and development company has developed a light therapy sleep mask costs £250 for 12 weeks’ treatment.
• Diabetes is the most common cause of preventable adult blindness in the developed world. Treating it costs the NHS about £1bn a year. Currently treatment costs of as much as £10,000 per patient for each eye.
• Trials have shown that eye disease can be reversed with significant results after as little as six months. Approximately 30 clinics around the country are trialling the product including Moorfields eye hospital. It is anticipated that Noctura 400 will receive NICE approval by the end of 2015.
Case Study: Fuel 3D Technologies
Oxford University Spin out Company, Fuel 3D Technologies has devised a novel 3D camera which allows for improved monitoring and clinical intervention of chronic wounds in clinics, hospitals and in patient homes.
• The Eykona Wound Measurement System, which was launched in the UK in December 2011 and is already being used in 20 NHS hospitals and primary care settings, allows community nurses to monitor the wounds while having the back-up of hospital-based experts.
• Images can be evaluated without the need for patients to visit outpatients – increasing effectiveness and reducing costs. The technology allows wounds to be assessed by volume giving a more accurate picture of wound healing.
£1,215,663 awarded£millions estimated savings
16 jobs created currently & £7m investment secured
Product available: from 2012
“Our success in securing SBRI Healthcare support increased market awareness and helped to validate the Eykona Wound Measurement System. The SBRI funding also carried significant weight with the wider investment community and was instrumental in helping us achieve our funding objectives,”
Stuart Mead, Chief Executive, Fuel3D
Case study:Advanced Digital Institute
• An estimated 5.3 million people suffer from chronic pain in England which has a major impact on sufferers’ lives, with 24% reporting a diagnosis of depression and 26% reporting an impact on employment.• Self-help digital products to support people with chronic pain. The technology will enable both patient and practitioner to have a balanced step-wise process to self-assess, self-manage, and self-monitor changes in pain.
£885,970.00 awardedEstimated savings to NHS at £20 million per annum
4 jobs created currently Product available: summer 2015
“One of things I really loved about it was that I got quite poorly for a few days and I started
struggling with my activity goals, and kept recording ‘I struggled, I struggled’. After a
couple of times the app flashed up and said ‘are you sure this goal isn’t too high for you –
do you want to adjust your goal’. I thought this is brilliant and so I changed it and started meeting it again and that was so much better
than keeping failing.”
Accelerating Innovation
Pathways through Chronic Pain is being developed as a cost-effective Cognitive Behavioural Therapy (CBT)-based pain management programme without the need for direct involvement by a therapist or clinician.
The emerging picture?
micro
small
medium
large
0 10 20 30 40 50 6054
26
5
7
start up
1-5 years
5-10 years
> 10 years
0 5 10 15 20 2514
23
13
16
<£100k£100-250k £250-£1m
£1-£10m>£10m
0 5 10 15 20 25 30 3528
2916
208
Size
Status
Turnover
AHSN/SBRI companies
Yorks & HumberHalliday James Ltd
East MidlandsMonica Healthcare Ltd
Eastern - Aseptika, Bespak, TwistDX
S.London, Imperial, UCLPABMS, Pintrack, Therakind, uMotif
WessexCreoMedical, Morgan Automation
North East & North CumbriaPolyphotonix Ltd
Kent, Surrey & SussexAnaxsys, InMezzo
Grter Manchester& NW Coast- Sky Med, TrusTECH
West MidlandsSensST Systems, Just Checking Ltd
West of EnglandSentiProfiling, My mHealth
South WestFrazer Nash
Oxford -Eykona, Oxford Biosignals, Message Dynamics
Scotland & N IrelandRadisens, Edixomed,
Nick Offer
SBRI Healthcare Programme Manager
01223 598425
www.sbrihealthcare.co.uk
@sbrihealthcare
The application process
Application Processwww.sbrihealthcare.co.uk
Application Process
Assessment Phase Timelines• Close competition, noon on 11th August• Review compliance (August)• Assessment packs assigned and issued to Technical Assessors
(August)• Each application reviewed & scored by 3 Technical Assessors
(Sept)• Assessment of long-list applications at panel meeting involving
clinical leads (Sept)• Production of rank ordered list for interview (Sept)• Interview panels to select final winners (Oct)• Draft and issue contracts (Nov)• Publish contracts awarded (Dec)• Feedback to unsuccessful applicants (Jan)
1. What will be the effect of this proposal on the challenge addressed? 2. What is the degree of technical challenge? How innovative is the project?3. Will the technology have a competitive advantage over existing/alternate technologies
that can meet the market needs? 4. Are the milestones and project plan appropriate? 5. Is the proposed development plan a sound approach?6. Does the proposed project have an appropriate commercialisation plan and does the
size of the market justify the investment? 7. Does the company appear to have the right skills and experience to deliver the
intended benefits? 8. Does the proposal look sensible financially? Is the overall budget realistic and justified
in terms of the aims and methods proposed?
Assessment Criteria
Key Points to Remember• Research and define the market/patient need • Review the direct competitor landscape and make sure you define your USP• Consider your route to market, what is the commercialisation plan? Do you
know who your customer will be, how will you distribute, how much will you charge for the product/service?
• How will the project be managed (what tools will you use, how will the team communicate etc)
• Provide a clear cost breakdown• Make sure you answer all of the questions in sufficient detail• Try not to use too much technical jargon, sell the project in terms the NHS will
understand (outcomes, benefits to patients etc)
Karen Livingstone SBRI Healthcare National [email protected] 257271
Nick OfferSBRI Healthcare Programme [email protected] 598425
www.sbrihealthcare.co.uk@sbrihealthcare
Contact Us
Faecal and urinary incontinence in frail elderly people
Multi-morbidities
Faecal incontinence is the inability to control the passage of faeces through the anus
Urinary incontinence is the involuntary loss of urine
• Incontinence is a set of symptoms not a disease• Can have either FI and UI or both• There is often an underlying cause that can be
treated• In some cases early treatment can prevent
incontinence later in life or reduce symptoms• It is very common, and more common in older
people, but need not be a consequence of ageing• At least 1 in 3 older people in nursing homes have
incontinence
• It is often present with other conditions, especially in the elderly
• Treatments for other co-morbidities can result in incontinence
• Many older people have cognitive impairment and this is a risk factor for incontinence
• Continence management is what we offer frail elderly people – usually pads or indwelling catheters
• Balance between independence and care by others
Aims
• To give older people a sense of dignity and control and enhance quality of life
• To reduce incontinence in our elderly population
Challenge 1: Prevention
What if we could break down the taboo surrounding incontinence
by informing and educating people of all ages into the causes
and how to prevent incontinence?
What if we can identify and monitor individuals who are at
risk?
Challenge 2: Diagnosis
What if we could accurately diagnose and treat all individuals with
faecal or urinary incontinence?
Challenge 3: Treatment
What if we could have cost-effective, reliable,
long-lasting, easy to use, minimally invasive,
biocompatible and safe treatments suitable for
older people?
Challenge 4: Management
What if we can offer personalised continence
management that offers patient dignity
and minimises the effects of social
stigma?
Frank
Edith
• http://www.slideshare.net/raheef/urinary-incontinence-48218342
• http://www.icud.info/incontinence.html
30 minute surgeries (phone or face-to-face) for applicants with continence clinical specialists to be held w/c 13 July in Bristol. Booking essential.Contact: [email protected]
Additional resources: